NCT07011433View on ClinicalTrials.gov

Pneumonia Pathogens' Virulence Factors, Patient Inflammatory Markers, and Their Associations With Outcomes

Enrolling by invitationOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

January 2, 2027

Study Completion Date

January 2, 2027

Conditions
Community Acquired Pneumonia (CAP)Hospital Acquired Pneumonia
Interventions
DIAGNOSTIC_TEST

Inflammatory Biomarker Evaluation

Venous blood samples are collected from subjects and analyzed for inflammatory biomarkers, including CD64, presepsin, IL-6, and IL-8, using a Luminex multiplex assay. Results are used for research purposes only and do not affect clinical management.

Trial Locations (1)

44307

Department of Laboratory Medicine, Lithuanian University of Health Sciences, Kaunas

All Listed Sponsors
lead

Ruta Nutautiene

OTHER